Royal Bank Of Canada Harrow Health, Inc. Transaction History

Royal Bank Of Canada

  • $479 Billion
  • Q4 2024

A detailed history of Royal Bank Of Canada transactions in Harrow Health, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 4,846 shares of HROW stock, worth $118,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,846
Previous 6,306 23.15%
Holding current value
$118,242
Previous $283,000 42.76%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$33.39 - $57.5 $48,749 - $83,950
-1,460 Reduced 23.15%
4,846 $162,000
Q3 2024

Nov 14, 2024
BUY
$20.85 - $46.47 $49,122 - $109,483
2,356 Added 59.65%
6,306 $283,000
Q2 2024

Aug 14, 2024
BUY
$10.0 - $21.64 $22,750 - $49,231
2,275 Added 135.82%
3,950 $82,000
Q1 2024

Nov 05, 2024
SELL
$9.3 - $13.23 $21,157 - $30,098
-2,275 Reduced 57.59%
1,675 $22,000
Q1 2024

May 15, 2024
SELL
$9.3 - $13.23 $75,860 - $107,917
-8,157 Reduced 82.96%
1,675 $22,000
Q4 2023

Feb 14, 2024
BUY
$8.1 - $16.36 $42,873 - $86,593
5,293 Added 116.61%
9,832 $110,000
Q3 2023

Nov 14, 2023
SELL
$14.03 - $22.08 $41,402 - $65,158
-2,951 Reduced 39.4%
4,539 $65,000
Q2 2023

Aug 14, 2023
BUY
$17.37 - $28.08 $82,021 - $132,593
4,722 Added 170.59%
7,490 $142,000
Q1 2023

May 15, 2023
SELL
$13.84 - $21.46 $15,016 - $23,284
-1,085 Reduced 28.16%
2,768 $58,000
Q4 2022

Feb 14, 2023
BUY
$10.28 - $14.78 $19,532 - $28,082
1,900 Added 97.29%
3,853 $56,000
Q3 2022

Nov 14, 2022
BUY
$6.57 - $24.88 $657 - $2,488
100 Added 5.4%
1,953 $24,000
Q2 2022

Aug 15, 2022
SELL
$5.75 - $7.74 $3,398 - $4,574
-591 Reduced 24.18%
1,853 $13,000
Q1 2022

May 16, 2022
BUY
$6.77 - $8.66 $4,001 - $5,118
591 Added 31.89%
2,444 $17,000
Q4 2021

Feb 14, 2022
SELL
$8.5 - $12.0 $150,671 - $212,712
-17,726 Reduced 90.54%
1,853 $16,000
Q3 2021

Nov 15, 2021
SELL
$6.99 - $10.6 $174,966 - $265,328
-25,031 Reduced 56.11%
19,579 $178,000
Q2 2021

Aug 16, 2021
BUY
$6.68 - $11.07 $297,994 - $493,832
44,610 New
44,610 $415,000

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $661M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email